NCT01432951 2020-10-12
A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma
Eli Lilly and Company
Phase 1 Completed
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company